These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29312802)

  • 21. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer.
    Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA
    Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unexpected alteration of β-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
    Umbreit C; Aderhold C; Faber A; Sommer JU; Sauter A; Hofheinz RD; Stern-Sträter J; Hoermann K; Schultz JD
    Anticancer Res; 2013 Jun; 33(6):2457-65. PubMed ID: 23749896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.
    Tuttle TR; Takiar V; Kumar B; Kumar P; Ben-Jonathan N
    Cancer Lett; 2017 Mar; 389():33-40. PubMed ID: 28025101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of lncRNA LINC00473 promotes radioresistance of HNSCC cells through activating Wnt/β-catenin signaling pathway.
    Han PB; Ji XJ; Zhang M; Gao LY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7305-7313. PubMed ID: 30468475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC.
    Shibata T; Cao DY; Dar TB; Ahmed F; Bhat SA; Veiras LC; Bernstein EA; Khan AA; Chaum M; Shiao SL; Tourtellotte WG; Giani JF; Bernstein KE; Cui X; Vail E; Khan Z
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calprotectin and the Initiation and Progression of Head and Neck Cancer.
    Argyris PP; Slama ZM; Ross KF; Khammanivong A; Herzberg MC
    J Dent Res; 2018 Jun; 97(6):674-682. PubMed ID: 29443623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).
    Wang Y; Chen C; Wang X; Jin F; Liu Y; Liu H; Li T; Fu J
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2461-2468. PubMed ID: 27601166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
    Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
    Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.
    Yang F; Zeng Q; Yu G; Li S; Wang CY
    Cell Signal; 2006 May; 18(5):679-87. PubMed ID: 16084063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced proliferation and colony formation of head and neck squamous cell carcinoma (HNSCC) after dual targeting of EGFR and hedgehog pathways.
    Liebig H; Günther G; Kolb M; Mozet C; Boehm A; Dietz A; Wichmann G
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):411-420. PubMed ID: 28110457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway.
    Chang WM; Chang YC; Yang YC; Lin SK; Chang PM; Hsiao M
    J Exp Clin Cancer Res; 2019 Jun; 38(1):245. PubMed ID: 31182137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory Effect of 1,8-Cineol on β-Catenin Regulation, WNT11 Expression, and Cellular Progression in HNSCC.
    Roettger A; Bruchhage KL; Drenckhan M; Ploetze-Martin K; Pries R; Wollenberg B
    Front Oncol; 2017; 7():92. PubMed ID: 28589081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
    Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS
    Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells.
    Huang K; Yang C; Wang QX; Li YS; Fang C; Tan YL; Wei JW; Wang YF; Li X; Zhou JH; Zhou BC; Yi KK; Zhang KL; Li J; Kang CS
    Cancer Lett; 2017 Mar; 388():269-280. PubMed ID: 27998759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol‑induced REG III expression enhances chemo‑ and radiosensitivity in head and neck cancer in xenograft mice.
    Mikami S; Ota I; Masui T; Uchiyama T; Okamoto H; Kimura T; Takasawa S; Kitahara T
    Oncol Rep; 2019 Jul; 42(1):436-442. PubMed ID: 31059079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.